Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic safety pharmacology: the cardiovascular system.

P Lacroix1, D Provost

  • 1Phoenix International Pharmacology, Le Genest Saint Isle, France. placroix@phoenix.fr

Therapie
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry.

Journal de medecine vasculaire·2023
Same author

[Social representations of cardiovascular disease in the Tanvè Health Study (TAHES) cohort in Benin].

Annales de cardiologie et d'angeiologie·2021
Same author

A massive rock and ice avalanche caused the 2021 disaster at Chamoli, Indian Himalaya.

Science (New York, N.Y.)·2021
Same author

[Prevalence of asthma among adults in France, data from the Constances cohort study].

Revue des maladies respiratoires·2021
Same author

Evolution of Major Amputation Risk in Patients Hospitalized in France for Critical Limb Ischemia: The COPART Registry.

Angiology·2020
Same author

Prevalence of stroke survivors in Parakou in northern Benin: A door-to-door community survey.

Revue neurologique·2020
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Safety pharmacology studies assess drug effects on the cardiovascular system, evaluating cardiac electrical activity and pump function. This strategy aims to detect adverse cardiovascular risks before clinical trials.

Area of Science:

  • Pharmacology
  • Cardiovascular Science
  • Drug Safety Evaluation

Background:

  • The cardiovascular system's integrity, encompassing electrical and pump functions, is crucial for hemodynamic stability.
  • Safety pharmacology mandates rigorous assessment of the cardiovascular system to identify potential drug-induced adverse effects.
  • Understanding cardiovascular responses is vital for preventing risks prior to human trials.

Purpose of the Study:

  • To outline a strategic approach for evaluating the cardiovascular safety of test substances.
  • To detail methods for detecting potential undesirable effects on the cardiovascular system.
  • To minimize cardiovascular risk associated with new drug development.

Main Methods:

  • A core program involves detailed hemodynamic evaluation in anesthetized dogs.

Related Experiment Videos

  • Complementary cardiac and cellular electrophysiology studies assess arrhythmogenic potential.
  • Early-stage rapid screening and supplementary studies are incorporated based on findings.

    • Main Results:

    • The described strategy provides a framework for comprehensive cardiovascular risk assessment.
    • It integrates various testing procedures from early discovery through clinical development.
    • The approach aims to identify and mitigate proarrhythmic or hemodynamic risks.

    Conclusions:

    • The proposed analytic strategy enables thorough evaluation of cardiovascular safety.
    • It supports informed decision-making in drug development by identifying potential risks early.
    • This systematic approach is essential for ensuring patient safety during clinical trials.